Want to see HK:2617 full AI Analyst Report?

TransThera Sciences (Nanjing). Inc. (2617) Financial Statements

5 Followers

TransThera Sciences (Nanjing). Inc. Financial Overview

TransThera Sciences (Nanjing). Inc.'s market cap is currently HK$3.14B. The company's EPS TTM is HK$; its P/E ratio is -8.32; TransThera Sciences (Nanjing). Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 20
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 1.18M	¥ 124.00K	¥ 61.76M
Gross Profit	¥ 0.00	¥ 0.00	¥ 1.18M	¥ 124.00K	¥ 0.00
Operating Income	¥ -300.18M	¥ -286.68M	¥ -390.52M	¥ -312.33M	¥ -43.86M
EBITDA	¥ -290.82M	¥ -267.97M	¥ -416.80M	¥ -346.90K	¥ -39.27M
Net Income	¥ -295.96M	¥ -274.61M	¥ -344.12M	¥ -250.04M	¥ -80.72M
Balance Sheet
Cash & Short-Term Investments	¥ 489.14M	¥ 572.53M	¥ 838.17M	¥ 1.11B	¥ 279.34M
Total Assets	¥ 545.91M	¥ 629.60M	¥ 887.09M	¥ 1.35B	¥ 344.94M
Total Debt	¥ 1.65M	¥ 4.37M	¥ 4.81M	¥ 3.04M	¥ 490.74M
Net Debt	¥ -413.76M	¥ -565.14M	¥ -491.82M	¥ -1.11B	¥ 412.54M
Total Liabilities	¥ 129.53M	¥ 104.57M	¥ 103.91M	¥ 111.04M	¥ 578.87M
Stockholders' Equity	¥ 416.38M	¥ 525.03M	¥ 783.18M	¥ 1.24B	¥ -233.94M
Cash Flow
Free Cash Flow	¥ -253.68M	¥ -271.95M	¥ -331.12M	¥ -244.00M	¥ -76.61M
Operating Cash Flow	¥ -253.51M	¥ -271.18M	¥ -319.33M	¥ -241.94M	¥ -66.68M
Investing Cash Flow	¥ -68.00M	¥ 348.42M	¥ -186.94M	¥ 26.98M	¥ -195.84M
Financing Cash Flow	¥ 169.00M	¥ -4.87M	¥ 15.76M	¥ 240.45M	¥ 311.48M

Currency in CNY

TransThera Sciences (Nanjing). Inc. Earnings and Revenue History

Income Statement >

TransThera Sciences (Nanjing). Inc. Debt to Assets

Balance Sheet >

TransThera Sciences (Nanjing). Inc. Cash Flow

Cash Flow >

TransThera Sciences (Nanjing). Inc. Forecast EPS vs Actual EPS

Earnings >